ORIGINAL RESEARCH
Published on 07 Oct 2025
Risk factors for steroid-refractory in immune checkpoint inhibitor-induced colitis: a retrospective cohort study
doi 10.3389/fimmu.2025.1623150
- 387 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Cancer Therapy Related Organ Toxicities
Cancer Therapy Related Organ Toxicities
7,831
Total downloads
33k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 03 Oct 2025
Immune checkpoint inhibitor-associated aseptic meningitis: a pharmacovigilance study using the FDA adverse event reporting system (2011–2024)
doi 10.3389/fimmu.2025.1654301
- 659 views
CASE REPORT
Published on 30 Sep 2025
Case Report: A case of reversible pulmonary bullae induced by camrelizumab: a new immune-related adverse event
doi 10.3389/fimmu.2025.1619702
- 706 views
ORIGINAL RESEARCH
Published on 25 Sep 2025
Increased acid sphingomyelinase levels in saliva as oral mucositis severity predictors
doi 10.3389/fonc.2025.1613884
- 2,542 views
CASE REPORT
Published on 10 Sep 2025
Successful rescue of PD-1 inhibitor-induced TEN by vincristine combination therapy: a case report and literature review
doi 10.3389/fonc.2025.1621494
- 726 views
CASE REPORT
Accepted on 09 Sep 2025
Immune-related Osteitis mimicking Femoral Head Osteonecrosis during Dual Checkpoint Blockade: A case report
doi 10.3389/fonc.2025.1621774
- 168 views
ORIGINAL RESEARCH
Published on 13 Aug 2025
Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors
doi 10.3389/fonc.2025.1575376
- 972 views
CASE REPORT
Published on 25 Jun 2025
Case Report: Immune checkpoint inhibitor-induced myositis without elevated creatine kinase
doi 10.3389/fimmu.2025.1592385
- 1,600 views
ORIGINAL RESEARCH
Published on 09 Jun 2025
Insights into immune-related adverse events in colorectal cancer patients receiving neoadjuvant immunotherapy: findings from a multicenter registry study
doi 10.3389/fimmu.2025.1529637
- 2,163 views
ORIGINAL RESEARCH
Published on 28 Apr 2025
Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy—a single center experience
doi 10.3389/fimmu.2025.1527103
- 1,524 views
CASE REPORT
Published on 04 Apr 2025
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
doi 10.3389/fimmu.2025.1563736
- 5,027 views
- 1 citation
CASE REPORT
Published on 01 Apr 2025
Immune checkpoint inhibitor-induced anti-Hu antibody-associated gastrointestinal pseudo-obstruction: a case report and literature review
doi 10.3389/fimmu.2025.1555790
- 1,932 views
- 2 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore